Log in   |   Join the community   


WILKOMMEN XEOMIN! The 3rd Neurotoxin Gets FDA Approval in the US

Posted by 08.02.10

Merz Pharmaceuticals receives US FDA approval on Xeomin® (incobotulinumtoxinA) botulinum toxin type A for the treatment of adults with cervical dystonia or blepharospasm.
The FDA approval of XEOMIN is based on the results of two pivotal U.S. clinical trials involving adult patients diagnosed with either cervical dystonia or blepharospasm.  XEOMIN is the only botulinum toxin that does not require refrigeration prior to reconstitution and it will be available in 50-unit and 100-unit vials.  XEOMIN is also free from complexing proteins. More than 84,000 patients have been treated with XEOMIN worldwide since 2005.  The U.S. is the 20thcountry to approve XEOMIN for the tr

Read More


  • Созраняй чтоб не потерять

We use cookies to offer a better user experience and to analyze site traffic. To comply with the European General Data Protection Regulation (GDPR), we are implementing a cookie consent manager to provide residents of the EU/EEA with the ability to customize their cookies. Until this is available, your continued use of this site will be deemed as consent to use of cookies.